Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 4, 2007, Pages 921-925

  Dhir, Ashish ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cyclic GMP; Forced swim test (FST); l arginine; Nitric oxide; Phosphodiesterase 5 inhibitor; Venlafaxine

Indexed keywords

7 NITROINDAZOLE; ARGININE; CYCLIC GMP; GUANYLATE CYCLASE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ARGININE; BEHAVIOR, ANIMAL; CYCLIC GMP; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; SIGNAL TRANSDUCTION; SWIMMING;

EID: 34247489688     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.02.008     Document Type: Article

References (27)

1. Almeida R.C., Felisbino C.S., Lopez M.G., Rodrigues A.L.S., and Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res 168 (2006) 318-322
2. Bender A.T., and Beavo J.A. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochem Int 45 (2004) 853-857
3. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411 (1999) 334-350
4. Dhir A., Naidu P.S., and Kulkarni S.K. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes. Addict Biol 10 (2005) 329-335
5. Ergun Y., and Ergun U.G. Prevention of pro-depressant effect of l-arginine in the forced swim test by N(G)-nitro-l-arginine and [1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one]. Eur J Pharmacol 554 (2007) 150-154
6. Eroglu L., and Caglayan B. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol Res 36 (1997) 381-385
7. Esplugues J.V. NO as a signalling molecule in the nervous system. Br J Pharmacol 135 (2002) 1079-1095
8. Gould G.G., Altamirano A.V., Javors M.A., and Frazer A. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry 59 (2006) 408-414
9. Gutierrez M.A., Stimmel G.L., and Aiso J.Y. Venlafaxine: a 2003 update. Clin Ther 25 (2003) 2138-2154
10. Harkin A., Connor T.J., Walsh M., St John N., and Kelley J.P. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44 (2003) 616-623
11. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14 (2004) 274-281
12. Heiberg I.L., Wegener G., and Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res 134 (2002) 479-484
13. Joca S.R., and Guimaraes F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berl) 185 (2006) 298-305
14. Kaster M.P., Ferreira P.K., Santos A.R.S., and Rodrigues A.L.S. Effect of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 165 (2005) 204-209
15. Kaster M.P., Rosa A.O., Santos A.R., and Rodrigues A.L. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int J Neuropsychopharmacol 8 (2005) 601-606
16. Kulkarni S.K., and Mehta A.K. Purine nucleoside-mediated immobility in mice: reversal by antidepressants. Psychopharmacology (Berl) 85 (1985) 460-463
17. Kulkarni S.K., and Patil C.S. Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 26 (2004) 789-799
18. Mantovani M., Pertile R., Calixto J.B., Santos A.R., and Rodrigues A.L. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway. Neurosci Lett 343 (2003) 1-4
19. Parale M.P., and Kulkarni S.K. Clonidine-induced behavioural despair in mice: reversal by antidepressants. Psychopharmacology 89 (1986) 171-174
20. Patil C.S., Singh V.P., and Kulkarni S.K. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil. Inflammopharmacology 13 (2005) 467-478
21. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47 (1978) 379-391
22. Reddy D.S., Kaur G., and Kulkarni S.K. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 9 (1998) 3069-3073
23. Redrobe J.P., Bourin M., Colombel M.C., and Baker G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138 (1998) 1-8
24. Renard C.E., Dailly E., David D.J., Hascoet M., and Bourin M. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 17 (2003) 449-455
25. Singh V.P., Jain N.K., and Kulkarni S.K. Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways. Methods Find Exp Clin Pharmacol 25 (2003) 273-280
26. Volke V., Wegener G., Bourin M., and Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140 (2003) 141-147
27. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res 959 (2003) 128-134